As of 2025-11-18, the Relative Valuation of Arecor Therapeutics PLC (AREC.L) is (659.92) GBP. This relative valuation is based on P/E multiples. With the latest stock price at 74.00 GBP, the upside of Arecor Therapeutics PLC based on Relative Valuation is -991.8%.
The range of the Relative Valuation is (718.23) - (506.45) GBP.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 32.8x - 49.1x | 41.0x |
| Forward P/E multiples | 15.4x - 23.1x | 19.2x |
| Fair Price | (718.23) - (506.45) | (659.92) |
| Upside | -1070.6% - -784.4% | -991.8% |
| Date | P/E |
| 2025-11-17 | -3.38 |
| 2025-11-14 | -3.38 |
| 2025-11-13 | -3.38 |
| 2025-11-12 | -3.38 |
| 2025-11-11 | -3.38 |
| 2025-11-10 | -3.47 |
| 2025-11-07 | -3.42 |
| 2025-11-06 | -3.31 |
| 2025-11-05 | -3.31 |
| 2025-11-04 | -3.31 |
| 2025-11-03 | -3.26 |
| 2025-10-31 | -3.26 |
| 2025-10-30 | -3.26 |
| 2025-10-29 | -3.26 |
| 2025-10-28 | -3.26 |
| 2025-10-27 | -3.26 |
| 2025-10-24 | -3.26 |
| 2025-10-23 | -3.26 |
| 2025-10-22 | -3.26 |
| 2025-10-21 | -3.10 |
| 2025-10-20 | -3.31 |
| 2025-10-17 | -3.31 |
| 2025-10-16 | -3.54 |
| 2025-10-15 | -3.54 |
| 2025-10-14 | -3.54 |
| 2025-10-13 | -3.54 |
| 2025-10-10 | -3.54 |
| 2025-10-09 | -3.54 |
| 2025-10-08 | -3.54 |
| 2025-10-07 | -3.54 |
| 2025-10-06 | -3.83 |
| 2025-10-03 | -3.83 |
| 2025-10-02 | -3.95 |
| 2025-10-01 | -3.95 |
| 2025-09-30 | -3.95 |
| 2025-09-29 | -3.95 |
| 2025-09-26 | -3.95 |
| 2025-09-25 | -3.95 |
| 2025-09-24 | -3.31 |
| 2025-09-23 | -3.31 |
| 2025-09-22 | -3.31 |
| 2025-09-19 | -3.31 |
| 2025-09-18 | -3.31 |
| 2025-09-17 | -3.29 |
| 2025-09-16 | -3.31 |
| 2025-09-15 | -3.31 |
| 2025-09-12 | -3.31 |
| 2025-09-11 | -3.31 |
| 2025-09-10 | -3.31 |
| 2025-09-09 | -3.31 |